» Articles » PMID: 10697645

Medical Management of HIV Disease in Children

Overview
Specialty Pediatrics
Date 2000 Mar 4
PMID 10697645
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Significant advances have been made in the understanding of the pathophysiology of HIV infection since the beginning of the epidemic. This knowledge has translated into the development of new therapies for HIV and opportunistic infections, laboratory advances in monitoring viral and immune status, and a better understanding of factors affecting patient outcome. Concomitantly, significant progress has been made in the medical management of children with HIV infection in the past 5 years. The number of children reported with AIDS in the United States is decreasing, and efforts are shifting from caring for children with advanced immunosuppression and severe opportunistic infections to early HAART, maintenance of the immune system, and prevention of opportunistic infections. Primary care physicians are now more involved and informed in the care of HIV-infected patients. Although published data are limited, physicians who have been working with this population have observed a dramatic improvement in the quality of life and length of survival of these patients. Unfortunately, this progress is not shared by developing countries where resources are minimal and antiretroviral agents are commonly unavailable. Although efforts to develop a vaccine to prevent HIV infection are ongoing, progress has been slow. Education and awareness continue to be the most powerful weapons against HIV.

Citing Articles

The Determinants of Elevated Pathobiological Determination of Atherosclerosis in Youth Risk Score in Perinatally HIV-Infected Adolescents in South Africa.

Mahtab S, Frigati L, Ntusi N, Nyathi M, Asafu-Agyei N, Myer L J Acquir Immune Defic Syndr. 2023; 95(1):82-89.

PMID: 37851954 PMC: 10840672. DOI: 10.1097/QAI.0000000000003304.


Risk Reduction Therapy for Adolescents: Targeting Substance Use and HIV/STI-Risk Behaviors.

McCart M, Sheidow A, Letourneau E Cogn Behav Pract. 2014; 21(2):161-175.

PMID: 25419101 PMC: 4235161. DOI: 10.1016/j.cbpra.2013.10.001.


Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus.

Patel K, Wang J, Jacobson D, Lipshultz S, Landy D, Geffner M Circulation. 2013; 129(11):1204-12.

PMID: 24366631 PMC: 3991841. DOI: 10.1161/CIRCULATIONAHA.113.001978.


Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children.

Miller T, Borkowsky W, DiMeglio L, Dooley L, Geffner M, Hazra R HIV Med. 2011; 13(5):264-75.

PMID: 22136114 PMC: 3297698. DOI: 10.1111/j.1468-1293.2011.00970.x.


Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.

Miller T, Somarriba G, Orav E, Mendez A, Neri D, Schaefer N J Acquir Immune Defic Syndr. 2010; 55(2):182-8.

PMID: 20531209 PMC: 2943965. DOI: 10.1097/QAI.0b013e3181e222c9.


References
1.
. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993. MMWR Morb Mortal Wkly Rep. 1996; 45(28):603-6. View

2.
Jacobson J, Greenspan J, Spritzler J, Ketter N, Fahey J, Jackson J . Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med. 1997; 336(21):1487-93. DOI: 10.1056/NEJM199705223362103. View

3.
Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G . Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med. 1998; 339(16):1093-9. DOI: 10.1056/NEJM199810153391601. View

4.
Nozyce M, Hittelman J, MUENZ L, Durako S, Fischer M, Willoughby A . Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics. 1994; 94(6 Pt 1):883-91. View

5.
Mofenson L, Korelitz J, Meyer 3rd W, Bethel J, Rich K, Pahwa S . The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous.... J Infect Dis. 1997; 175(5):1029-38. DOI: 10.1086/516441. View